| Accession Number: | 0001104659-21-121964 |
| Date: | 2021-09-30 |
| Issuer: | NABRIVA THERAPEUTICS PLC (NBRV) |
| Original Submission Date: |
NAFTZGER J. CHRISTOPHER
414 COMMERCE DR.
SUITE 120
FORT WASHINGTON, PA 19034
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SHARE OPTION | 1.19 | 2021-09-30 | deemed execution date | A | 100,000 (a) | 2031-09-29 | ordinary shares 100,000 | $1.19 | 100,000 | direct |
| ID | footnote |
|---|---|
| f1 | the option was granted on september 30, 2021. |
| f2 | the option will vest over a four-year period. twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period. |
